Patients with a hypertensive response to exercise have impaired systolic function without diastolic dysfunction or left ventricular hypertrophy  by Mottram, Philip M. et al.
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atients With a Hypertensive Response to
xercise Have Impaired Systolic Function Without
iastolic Dysfunction or Left Ventricular Hypertrophy
hilip M. Mottram, MBBS, FRACP, Brian Haluska, MS, Satoshi Yuda, MD, Rodel Leano, BS,
homas H. Marwick, MBBS, PHD, FACC
risbane, Australia
OBJECTIVES We sought to determine if a hypertensive response to exercise (HRE) is associated with
myocardial changes consistent with early hypertensive heart disease.
BACKGROUND An HRE predicts the development of chronic hypertension (HT) and may reflect a preclinical
stage of HT.
METHODS Patients with a normal left ventricular (LV) ejection fraction and a negative stress test were
recruited into three matched groups: 41 patients (age 56  10 years) with HRE (210/105
mm Hg in men; 190/105 in women), comprising 22 patients with (HT) and 19 without
resting hypertension (HT); and 17 matched control subjects without HRE. Long-axis
function was determined by measurement of the strain rate (SR), peak systolic strain, and
cyclic variation (CV) of integrated backscatter in three apical views.
RESULTS An HRE was not associated with significant differences in LV mass index. Exercise
performance and diastolic function were reduced in HRE(HT) patients, but similar in
HRE(HT) patients and controls. Systolic dysfunction (peak systolic strain, SR, and CV)
was significantly reduced in HRE patients (p  0.001 for all). These reductions were equally
apparent in patients with and without a history of resting HT (p  NS) and were
independent of LV mass index and blood pressure (p  0.01).
CONCLUSIONS An HRE is associated with subtle systolic dysfunction, even in the absence of resting HT.
These changes occur before the development of LV hypertrophy or detectable diastolic
dysfunction and likely represent early hypertensive heart disease. (J Am Coll Cardiol 2004;
43:848–53) © 2004 by the American College of Cardiology Foundationc
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fhypertensive response to exercise (HRE) is associated
ith an increased incidence of chronic hypertension (HT)
uring follow-up and has been proposed as a preclinical
tage of HT (1). However, it is currently unclear as to
hether HRE is associated with hypertensive end-organ
amage or other cardiovascular complications.
Early cardiovascular disease may be identified using
everal new techniques, including quantitative echocardio-
raphic parameters with strain rate (SR) imaging and
ntegrated backscatter (IB). Application of these recently
eveloped techniques to patients with HRE may allow the
etection of subtle abnormalities of myocardial function.
he aims of the study were to determine whether patients
ith HRE (without resting HT) have detectable abnormal-
ties of myocardial function and to determine the relation of
arly systolic dysfunction to left ventricular (LV) hypertro-
hy and diastolic dysfunction in these patients.
ETHODS
atient selection. We screened 400 consecutive patients
eferred for exercise electrocardiography or exercise echo-
From the University of Queensland, Brisbane, Australia. This study was supported
n part by a scholarship from the National Heart Foundation of Australia.
Manuscript received March 14, 2003; revised manuscript received August 21, 2003,
(ccepted August 25, 2003.ardiography for clinical indications, mostly for investiga-
ion of chest pain syndromes. Patients with a history of
schemic heart disease were excluded. Exercise tests were
erformed using the Bruce protocol, with blood pressure
BP) by sphygmomanometry at the end of each 3-min stage.
ntry criteria included the presence of normal regional and
lobal resting systolic LV function, no significant (mild)
alvular dysfunction, and a negative maximum exercise
lectrocardiogram or exercise echocardiogram for inducible
yocardial ischemia. A positive (HT) or negative (HT)
linical history of HT was defined by elevated BP (140/90
m Hg) documented by the referring physician and treated
ith antihypertensive medication. High normal blood pres-
ure was defined as that exceeding 130/80 mm Hg. Resting
lood pressure was measured at the time of the echocardi-
graphy. A hypertensive response to maximum exercise was
efined by maximum systolic/diastolic BP 210/105 mm
g in males and 190/105 mm Hg in females (1,2).
chocardiography. A detailed two-dimensional and
oppler echocardiogram (Vivid Five, GE Vingmed, Hor-
on, Norway) was obtained in all patients. Left ventricular
-mode measurements of wall thickness and end-diastolic
nd end-systolic diameters were used for calculation of
ractional shortening, relative wall thickness, and LV mass
3). Left ventricular hypertrophy was defined as LV mass
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March 3, 2004:848–53 Exercise Hypertension and Myocardial Dysfunctionndex 116 g/m2 in males and 104 g/m2 in females (4).
omprehensive assessment of LV diastolic function in-
luded transmitral and pulmonary vein pulsed wave Doppler
maging from the apical four-chamber view, LV color flow
ropagation velocity, and mitral annular diastolic velocities
ith tissue Doppler imaging. Transmitral early diastolic
elocity and deceleration time, late diastolic velocity, and
sovolumic relaxation time were recorded. Systolic and
iastolic velocities were measured in the right upper pulmo-
ary vein, as was the velocity of the atrial reversal wave. Left
entricular color flow propagation velocity was measured as
he slope of the first aliasing velocity of the early diastolic
ignal, from the plane of the mitral valve to a point 4 cm
nto the LV cavity (5). Systolic and early (Ea) and late (Aa)
iastolic velocities were measured at the medial and lateral
itral annulus with pulsed wave tissue Doppler imaging in
he apical four-chamber view. The ratio of peak early
iastolic velocity to Ea was used to estimate LV filling
ressures (6), and the Tei index was determined as an
dditional parameter of myocardial performance (7). Mea-
urements were performed off-line and averaged from three
onsecutive cardiac cycles. Satisfactory measurements were
btained with all modalities except flow propagation veloc-
ty, which was obtainable in 57 subjects (98%).
train rate imaging. Three consecutive cardiac cycles of
olor Doppler data were digitally recorded in each of six
alls (i.e., septum, lateral, anterior, inferior, anteroseptum,
nd posterior) in three standard apical views. Strain and SR
re sensitive measures of long-axis systolic LV function that
epresent dimensionless descriptions of length changes due
o the deformation of tissue caused by applied or developed
orce. The rate of regional myocardial deformation (SR) was
erived from instantaneous differences in myocardial veloc-
ties within an 11-mm region of interest (8), using devel-
pmental software (TVIv61, GE Vingmed, Milwaukee,
isconsin). Percent deformation of the segment (myocar-
ial strain) was obtained by integration of the SR curve.
ean SR and peak systolic strain were calculated in each
atient by averaging the results of each wall and were
btainable in 343 (99%) of 348 segments.
ntegrated backscatter. Long-axis systolic LV function
as also assessed by cyclic variation (CV) of IB, as a means
f corroborating the SR results. Gray-scale loops of three
onsecutive cardiac cycles were acquired at frame rates of 80
Abbreviations and Acronyms
Aa  late diastolic mitral annular velocity
BP  blood pressure
CV  cyclic variation
Ea  early diastolic mitral annular velocity
HRE  hypertensive response to exercise
HT  hypertension
IB  integrated backscatter
LV  left ventricle/ventricular
SR  strain rateso 120 frames/s in three standard apical views, saved in raw
ata format, and analyzed off-line (Echopac 6.1, GE Ving-
ed, Milwaukee, Wisconsin). The IB information in the
hree cycles was averaged; then, the CV of IB during systole
as determined for each of the 16 LV segments (9) by
racking a fixed 11  11 pixel region of interest in the
id-myocardium in each frame. The magnitude of CV was
etermined by the difference between the minimum and
aximum values of IB in a cardiac cycle (10). Mean CV was
alculated in each patient by averaging the results of 16
ndividual segments.
Calibrated IB, a measure of myocardial ultrasound reflec-
ivity or tissue density, was obtained from the septum and
osterior wall in the parasternal view by subtracting average
ericardial IB intensity from average myocardial IB inten-
ity (11). Measurements were obtained by adjusting the
osition of the sample volume in each frame so that it was
aintained within the same region of the septum, posterior
all, or pericardium throughout the cardiac cycle. The CV
f IB was measurable in 874 (94%) of 928 segments, and
alibrated IB in 108 (93%) of 116 segments.
ample size and statistical analysis. Sample size calcula-
ions were based on previous data from our laboratory
omparing patients with hypertensive LV hypertrophy with
ontrol subjects (10). These results revealed a 17% to 22%
eduction in CV of IB, SR, and peak systolic strain in
atients with hypertensive LV hypertrophy. By applying the
ariance seen in these patients, a significant difference (p 
.05) of 15% between groups was predicted with a sample
ize of 17 patients per group at 90% power for CV of IB and
90% for SR and peak systolic strain.
Continuous variables are presented as the mean value 
D. Group differences were compared using analysis of
ariance (ANOVA); post-hoc multiple group comparisons
ere assessed with the Bonferroni method, adjusting for
hree-way comparisons. Linear regression was used to de-
ermine correlations between continuous variables. The
elationship of strain and IB parameters with LV mass, BP,
nd body weight was examined in a multiple linear regres-
ion model. Data were analyzed using standard statistical
oftware (SPSS version 9, Chicago, Illinois). A p value of
0.05 was considered significant.
ESULTS
linical and exercise characteristics. Of the screened
roup, 41 patients (19 HT and 22 HT) demonstrated
RE and met the entry criteria. There were no significant
ge or gender differences between the HT and HT
atients and the 17 age- and gender-matched control
ubjects with no clinical history of HT and a normotensive
esponse to exercise (Table 1).
The HRE(HT) patients had high normal resting BP
mean value 136/86 mm Hg) with elevated BP at peak
xercise, but an exercise duration and maximal work load
imilar to controls. The HRE(HT) patients had higher
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Exercise Hypertension and Myocardial Dysfunction March 3, 2004:848–53esting BP, higher peak systolic BP, and lower exercise
erformance compared with both HRE(HT) patients and
ontrols. The increase in systolic BP normalized for exercise
apacity was similar in both HRE groups (Table 1).
chocardiographic findings. The HRE(HT) patients
ad cardiac dimensions and LV mass index similar to
ontrol subjects (Table 2). The HRE(HT) patients had
ncreased wall thickness and relative wall thickness but did
ot have a significantly different LV mass index (p  0.08
y ANOVA). Only 4 of the 41 patients with HRE had LV
Table 1. Clinical and Exercise Data
Males
Age (yrs)
Diabetes
Smoking
Hypercholesterolemia
Body mass index (kg/m2) 2
Exercise data
Resting mean BP (mm Hg)
Peak heart rate (beats/min)
Peak mean BP (mm Hg)
Peak systolic BP (mm Hg)
Indexed systolic BP increase (mm Hg/MET)
Exercise duration (min) 1
Work load (METs) 1
ST-segment deviation (mm)
Duke treadmill score
*p  0.05 versus controls, †p  0.001 versus controls, ‡
HRE(HT) patients; comparisons made using the Bonferr
number (%) of control subjects or patients.
ANOVA analysis of variance; BP blood pressure; HR
and negative clinical history of hypertension, respectively; M
Table 2. Two-Dimensional and Conventional
Contr
Cardiac dimensions
LV diastolic diameter (cm) 4.89 
Septal thickness (cm) 0.86 
Posterior wall thickness (cm) 0.86 
Relative wall thickness 0.35 
Fractional shortening (%) 37.9 
LV mass index (g/m2) 79.7 
Left atrial area (cm2) 18.4 
Transmitral Doppler imaging
Early diastolic velocity (cm/s) 68 
Late diastolic velocity (cm/s) 61 
Early/late diastolic velocity ratio 1.16 
Early diastolic deceleration time (ms) 202 
Isovolumic relaxation time (ms) 80 
Pulmonary vein Doppler imaging
Peak systolic velocity (cm/s) 54 
Peak diastolic velocity (cm/s) 39 
Systolic/diastolic ratio 1.42 
Atrial reversal velocity (cm/s) 29 
*p 0.05 versus controls, †p 0.01 versus controls, and ‡p
adjustment. Data are presented as the mean value  SD.LV  left ventricular. Other abbreviations as in Table 1.ypertrophy, three of whom were in the HRE(HT)
ubgroup.
The HRE(HT) patients had impaired LV diastolic
unction, as evidenced by a reduced early/late diastolic
elocity ratio, prolonged deceleration time and isovolumic
elaxation time, and reduced velocities of flow propagation
nd lateral Ea (Tables 2 and 3). The early/late diastolic velocity
atio and lateral Ea velocity were less in HRE(HT) than in
RE(HT) patients. The HRE(HT) patients showed no
bnormalities in diastolic function (Table 3). There was no
trol
ects
17)
HRE(HT)
Patients
(n  19)
HRE(HT)
Patients
(n  22)
p Value
(ANOVA)
%) 9 (47%) 9 (41%) NS
5 53  9 58  11 NS
1 2 NS
4 1 NS
%) 10 (53%) 17 (77%) NS
3.1 27.7  4.8 29.9  5.6* 0.004
6 98  10† 109  16†‡  0.001
15 164  16 159  20 NS
17 132  7† 137  12†  0.001
23 203  11† 218  16†‡  0.001
2.1 8.8  5.9* 9.4  3.5* 0.002
2.1 9.8  2.1 6.7  2.6†§  0.001
2.6 10.3  3.0 7.6  2.7†‡ 0.001
0.7 0.3  0.5 0.2  0.3 NS
4.6 8.3  2.1 5.8  2.8‡ 0.024
.05 versus HRE(HT) patients, and §p  0.001 versus
justment. Data are presented as the mean value  SD or
ypertensive response to exercise; HT and HT positive
metabolic equivalent; NS  not significant.
pler Echocardiographic Data
HRE(HT) HRE(HT)
p Value
(ANOVA)
5.06  0.44 5.01  0.45 NS
0.95  0.12 0.99  0.14† 0.005
0.92  0.14 0.97  0.12* 0.023
0.37  0.05 0.39  0.05* 0.043
40.8  7.3 39.6  9.1 NS
85.4  16.6 90.1  20.2 NS
20.3  4.2 19.9  3.4 NS
65  19 65  17 NS
59  18 73  15‡ 0.009
1.14  0.28 0.92  0.28*‡ 0.012
219  26 235  41† 0.008
87  14 92  16* 0.040
61  11 52  13 NS
43  9 40  16 NS
1.44  0.32 1.41  1.41 NS
32  4 33  7 0.054
versus HRE(HT); comparisons made using the BonferroniCon
Subj
(n 
6 (35
53 
0
4
9 (53
4.6 
86 
171 
109 
167 
4.7 
0.2 
1.1 
0.4 
8.3 
p  0
oni ad
E hDop
ols
0.40
0.09
0.09
0.03
7.0
14.0
3.3
12
13
0.23
24
15
8
8
0.21
3
0.05
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March 3, 2004:848–53 Exercise Hypertension and Myocardial Dysfunctionignificant difference in mitral annular peak systolic velocities
etween HRE patients and control subjects.
The ratios of peak early diastolic transmitral velocity to
a for HRE(HT) and HRE(HT) patients and controls
ere 7.3, 6.6, and 6.7 (p  0.31), respectively, using septal
a, and 6.4, 5.9, and 5.6 (p  0.25), respectively, using
ateral Ea. These results suggest that LV filling pressures
ere normal in study patients and similar in all three groups.
esults for the Tei index were concordant with the abnor-
alities of diastolic function demonstrated in the
RE(HT) group (Tables 2 and 3). This parameter
ncreased between controls (0.409  0.178), HRE(HT)
atients (0.504  0.153), and HRE(HT) patients (0.603
0.187; p 0.004), consistent with a stepwise reduction in
yocardial performance. Post hoc testing with Bonferroni
djustment revealed a significant difference between
RE(HT) patients and controls (p  0.003), but the
ifference between HRE(HT) patients and controls was
ot significant (p  0.22).
train and IB. Patients with HRE had impaired long-axis
V function, as evidenced by significantly reduced SR, peak
ystolic strain, and CV of backscatter (Figs. 1 and 2). These
eductions were equally apparent in patients with and
ithout a history of resting HT.
Table 3. Tissue Doppler-Derived Mitral Annu
Controls
Septum
Ea (cm/s) 10.2  1.3
Aa (cm/s) 10.7  1.4
Ea/Aa ratio 0.97  0.1
Sa (cm/s) 7.9  0.9
Lateral wall
Ea (cm/s) 12.5  2.9
Aa (cm/s) 11.7  2.5
Ea/Aa ratio 1.15  0.4
Sa (cm/s) 9.9  1.9
Flow propagation velocity (cm/s) 80  17
*p  0.05 versus controls, †p  0.001 versus controls, an
Bonferroni adjustment. Data are presented as the mean valu
Aa  late diastolic mitral annular velocity; Ea  early dia
other abbreviations as in Table 1.
igure 1. Mean segmental strain rate and peak systolic strain at rest in
ypertensive response to exercise (HRE) patients with and without
ypertension (HT) and in control subjects. *p  0.001 versus controls
sing the Bonferroni adjustment. cIn a multiple linear regression model, the lower values of
R (p  0.001), peak strain (p  0.01), and CV (p  0.01)
n HRE patients remained significant after correcting for
he effects of differences in LV mass index, systolic and
iastolic BP, and body weight. In HRE patients, there was
trend toward a negative correlation of peak systolic strain
ith diastolic BP (r  0.32, p  0.054), but not systolic
P (r  0.15, p  0.38). There was no relation of BP to
ither SR or CV. Thirteen of the 22 HRE(HT) patients
ere taking negatively inotropic agents for treatment of
T. There was no difference in SR (p  0.29) or peak
ystolic strain (p  0.88) between those taking and those
ot taking these agents. Interestingly, CV was higher in
atients on negatively inotropic medication (6.72 vs. 5.82
B, p  0.02).
In contrast to the observed reductions in myocardial
ystolic function, HRE patients showed no disturbances in
yocardial reflectivity (Table 4), suggesting that myocardial
ensity is not altered in this group.
elocities and Flow Propagation Velocity
HRE(HT) HRE(HT)
p Value
(ANOVA)
10.7  2.0 9.3  2.3 0.065
11.1  2.1 10.4  2.2 NS
0.99  0.22 0.92  0.29 NS
8.0  1.7 8.0  2.0 NS
12.3  2.6 10.3  1.9*‡ 0.015
11.6  2.5 11.2  2.2 NS
1.12  0.38 0.96  0.28 NS
9.1  2.1 8.8  1.5 NS
69  22 57  20† 0.004
 0.05 versus HRE(HT); comparisons made using the
D.
itral annular velocity; Sa  mitral annular systolic velocity;
igure 2. Cyclic variation of integrated backscatter (IB) in hypertensive
esponse to exercise (HRE) patients with and without hypertension (HT)
nd in control subjects. *p  0.002 versus controls, †p  0.001 versuslar V
3
9
d ‡p
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lthough HRE patients had similar exercise capacity, car-
iac dimensions, and diastolic function, compared with
ontrol subjects with a normotensive exercise response, they
emonstrated a mild decrease in LV segmental deforma-
ion. This impairment of LV long-axis systolic function was
vident even in patients without a history of resting HT.
hese results suggest that cardiac damage is evident in a
atient group that many observers would consider to be
prehypertensive” (12).
RE in patients without diagnosed HT. Although it is not
urprising that HRE patients with background HT (albeit
argely controlled) have mildly abnormal LV function, the
etection of abnormal function in the HT group is a
ignificant finding. These HRE(HT) patients had high
ormal (13) resting BP (mean 136/86 mm Hg), and previous
tudies have demonstrated that subjects with high normal BP
ave a several-fold increased risk of progression to HT during
ollow-up (14) and are at increased risk of cardiovascular events
15). Furthermore, an HRE itself is associated with the
ubsequent development of HT (1). The present study under-
cores the importance of HRE in association with high normal
P by demonstrating that subtle myocardial dysfunction is
lready present in these patients.
ardiac complications of early HT and HRE. LEFT
ENTRICULAR HYPERTROPHY. The lack of association be-
ween HRE and LV hypertrophy in the present study is
onsistent with the results of the Framingham investigators
2), which showed no difference in the prevalence of LV
ypertrophy in HRE after correcting for age, systolic BP,
nd body mass index. Indeed, previous studies suggesting
hat LV hypertrophy (rather than dysfunction) is the earliest
ardiac abnormality in both early HT (16) and HRE (17)
id not include sensitive measures of systolic and diastolic
unction. Furthermore, in the present study, there was no
ignificant correlation of either strain or backscatter indexes
ith LV mass index in HRE patients, and the reductions in
hese parameters, compared with controls, remained signif-
cant after correcting for group differences in LV mass
ndex. Such results suggest that abnormalities of strain and
ackscatter in HRE patients relate to a degree of myocardial
amage and are not explained by myocardial hypertrophy.
IASTOLIC FUNCTION. Diastolic dysfunction is thought to
evelop relatively early in the course of systemic HT, and
ormer clinical studies have suggested that diastolic dysfunc-
ion precedes systolic dysfunction in the progression of
able 4. Values of Integrated Backscatter (IB) in the Septum
nd Posterior Wall, Corrected for Pericardial IB
Calibrated IB Controls HRE(HT) HRE(HT)
eptum (dB) 21.0  10.3 21.5  6.7 19.3  6.9
osterior wall (dB) 28.5  7.6 30.1  5.0 28.9  5.6
 NS for all comparisons. Data are presented as the mean value  SD.
Abbreviations as in Table 1.ypertensive heart disease (18). In these studies, however,ystolic LV function was assessed with chamber dynamics,
hich do not accurately reflect myocardial systolic function
n the presence of concentric remodeling (19). In the
resent study, patients at an earlier stage of HT had normal
V structure (dimensions, mass, and calibrated IB) and
ormal transmitral flow; however, despite reduced annular
iastolic velocity in only hypertensive patients with HRE,
arameters of impaired long-axis contractility were present
n all HRE patients. These findings suggest that segmental
ystolic dysfunction occurs before global diastolic dysfunc-
ion and may be the earliest abnormality in hypertensive
eart disease. However, they do not exclude the presence of
egmental diastolic dysfunction in this group, as diastolic
R imaging was not performed.
YSTOLIC DYSFUNCTION. Although overt systolic dysfunc-
ion is associated with advanced hypertensive heart disease,
nimal studies have demonstrated impaired velocity of
yocardial contraction in the presence of hypertensive
ypertrophy (20). Similarly, despite the presence of a
ormal ejection fraction in patients with hypertensive LV
ypertrophy, human studies have shown reduced mid-wall
hortening (21), which is an independent predictor of
ardiac death in hypertensive patients (22). The present
tudy extends these findings by demonstrating impaired
ystolic LV function in both hypertensive patients with
inimal increases in LV mass and HRE patients with
ormal LV mass and normal global diastolic function.
A recent study of hypertensive patients with concentric
emodeling found that fractional shortening and systolic
itral annular velocities were decreased in the long axis, but
ot in the short axis, as compared with controls (23). These
esults suggest that impairment of long-axis systolic func-
ion may occur before changes in radial contractile function
n hypertensive heart disease and are consistent with re-
uced long-axis strain and IB parameters demonstrated in
atients without concentric remodeling in the present study.
echanism of LV dysfunction in HRE. The mechanism
f subtle systolic dysfunction in HRE patients is unclear.
lthough it may reflect periodic surges in BP related to
xertion and possibly emotional stress, in the majority of
atients, BP only reached excessive levels at or near peak
xercise and was in the normal range at work loads reflective
f normal daily activities. We therefore suspect that myo-
ardial dysfunction developed after long-term exposure to
igh normal levels of BP.
Although we believe that reductions in SR and backscat-
er parameters in HRE patients reflect intrinsic myocardial
amage, an alternative explanation might invoke the pres-
nce of increased afterload. However, several lines of evi-
ence refute the suggestion that afterload differences are
esponsible for our results. First, previous work in patients
ith hypertensive LV hypertrophy has shown that afterload
s not a determinant of shortening in the long-axis plane
21). Second, previous work with systolic myocardial veloc-
ty (the local gradient of which is used to generate SR
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March 3, 2004:848–53 Exercise Hypertension and Myocardial Dysfunctionurves) showed this was relatively independent of hemody-
amic factors (24). Third, the strain results are indepen-
ently supported by CV of IB, which is relatively indepen-
ent of load (25). Finally, there was no significant
elationship between BP and long-axis systolic function in
he present study; indeed, despite a progressive increment in
esting mean BP in control subjects and HRE(HT) and
RE(HT) patients, strain and CV parameters were
educed equally in both of the HRE groups. Thus, although
R is unlikely to be entirely independent of afterload, the
ffects at physiologic loads are likely to be small.
linical implications. As our understanding of the risk of
nd-organ damage due to HT has evolved, guidelines for
arget BP in hypertensive patients have periodically been
evised downward. The present study adds further support
o this trend by identifying impaired myocardial function in
atients with high to normal resting BP who exhibit HRE.
hese changes may represent the earliest cardiac abnormal-
ty in hypertensive heart disease and may identify patients at
isk of developing clinical heart failure.
The findings suggest that SR imaging and CV of IB are
romising quantitative techniques for noninvasive myocar-
ial characterization, which may aid in the early detection of
ypertensive heart disease. More importantly, they may
llow monitoring of the response to treatment interventions
ith greater sensitivity than, for example, serial measure-
ent of LV dimensions with M-mode imaging. Important
uestions to be addressed include whether the observed
ystolic dysfunction is reversible with effective treatment of
T, and what is the relation of decreased CV and strain
arameters to clinical risk?
eprint requests and correspondence: Prof. Thomas H. Mar-
ick, Department of Medicine, University of Queensland, Prin-
ess Alexandra Hospital, Ipswich Road, Brisbane Q4102, Austra-
ia. E-mail: tmarwick@soms.uq.edu.au.
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